Epidemiology of Alzheimer’s Disease and Dementia in Arab Countries: A Systematic Review

Abstract

Background/Objectives Contrary to popular belief, the condition of dementia is not an actual discrete disease, but rather a group of symptoms, most notable of which is the disturbance of memory and social ability, often severe enough to impair daily functioning. As a result, it has been a major cause of functional deterioration among varying populations in the world. This study is aimed at reviewing the epidemiology of dementia in Arab countries in terms of its prevalence, distribution, and risk factors. Methods A systematic literature review was conducted using articles published in PubMed, Embase, Scopus, and other local journals between 1990 and 2018. After applying the inclusion and exclusion criteria, a total of 18 studies were concluded to be eligible for the review. Results Prevalence studies demonstrated that dementia is indeed a prevalent condition in Arab countries, ranging between 1.1% and 2.3% among age groups of 50 years and older, as well as between 13.5% and 18.5% among age groups of 80 years and above. However, these results are not different from those of many other countries in the world. Moreover, prevalence was found to vary depending on sociodemographic characteristics. Major risk factors of dementia included hypertension, low income, and low education, while the risk of developing dementia is increased by obesity, diabetes mellitus, and cardiovascular risk factors. Despite the growing evidence regarding the epidemiological distribution and determinants of dementia worldwide, studies from the Arab region remain scarce. Conclusion This systematic review highlights the need for population-based studies to provide necessary information for developing preventive and curative strategies specific to the Arab region.

20(S)-protopanaxadiol and oleanolic acid ameliorate cognitive deficits in APP/PS1 transgenic mice by enhancing hippocampal neurogenesis

“…In addition to the pathologic factors discussed above, age is the greatest risk factor for developing AD, with most cases of AD occurring in those over 65 years of age [ 29 ]. Hippocampal neurogenesis is thought to persist throughout the course of life; however, a remarkable decline in neurogenesis occurs with age [ 30 ].…”

A Systematic Review of Clinical Decision Support Systems in Alzheimer’s Disease Domain

“…For every 67 seconds someone in the United States develops AD [7]. Prevalence of dementia in the Arab countries ranges about (a) 1.1% -2.3% in 50 years of age and above, (b) 13.5%-18.5% in 80 years of age and above which is almost same as other countries in the world [8]. Most recent WHO data published in 2018 indicates that Alzheimer's and Dementia death rate in Oman is 397 or 3.86% of total deaths.…”

A novel variant c.3706C>T p.(Avg 1236Cys) in the <i>ABCA7</i> gene in a Saudi patient with susceptibility to Alzheimer's disease 9

“…The prevalence of AD in Arab countries is not accurately evaluated in comprehensive epidemiological studies (11). In Saudi Arabia, there are approximately 130,000 persons suffering from AD representing 0.4% of the Saudi population.…”